Fibrotic aortic valve disease after radiotherapy: an immunohistochemical study in breast cancer and lymphoma patients

Jan Willem van Rijswijk (Corresponding author), Emile S. Farag, Carlijn V.C. Bouten, Onno J. de Boer, Allard van der Wal, Bas A.J.M. de Mol, Jolanda Kluin (Corresponding author)

Onderzoeksoutput: Bijdrage aan tijdschriftTijdschriftartikelAcademicpeer review

1 Downloads (Pure)

Uittreksel

BACKGROUND: Radiation-associated aortic valve (AV) stenosis is frequently seen as a late sequela after thoracic radiotherapy (RT). Although the clinical relationship between thoracic radiotherapy and valvular dysfunction has been established, the process leading to accelerated aortic valve stenosis remains unclear. The aim of this study was to determine whether increased inflammatory cell infiltration, fibrosis, and calcification is present in aortic valves after radiotherapy at the time of aortic valve replacement.

METHODS: Stenotic aortic valve specimens from 43 patients were obtained after surgical aortic valve replacement. A total 28 patients had previously undergone radiotherapy for breast cancer or malignant lymphoma. A total 15 patients were included as control. The valve leaflets were assessed by (immuno)histochemistry for inflammatory cell composition (CD3, CD20, CD68, and CD163) and extracellular matrix changes (collagen and calcification).

RESULTS: Aortic valve cell density after radiotherapy for lymphoma was markedly decreased when compared with other groups. Irradiated aortic valve show similar (low) degrees of late T and B lymphocyte infiltration as control valves, whereas macrophage marker CD68 was decreased after radiotherapy for breast cancer. Collagen content was increased following radiotherapy. Aortic valves of patients with lymphoma contained significantly less calcified tissue when compared with the other groups.

CONCLUSION: High-dose radiation at a young age (patients with lymphoma) results in cell loss and premature fibrotic aortic valve stenosis as opposed to the degenerative calcific stenosis observed in patients with breast cancer. Our findings suggest a possible dose-dependent effect of radiotherapy on aortic valve fibrosis. The active presence of inflammatory cells may be limited to the acute phase after radiotherapy.

Originele taal-2Engels
Artikelnummer107176
Aantal pagina's7
TijdschriftCardiovascular Pathology
Volume45
DOI's
StatusGepubliceerd - 1 mrt 2020

Vingerafdruk

Aortic Diseases
Aortic Valve
Lymphoma
Radiotherapy
Breast Neoplasms
Aortic Valve Stenosis
Fibrosis
Collagen
Thorax
Radiation
Surgical Instruments
Extracellular Matrix
Pathologic Constriction
B-Lymphocytes
Cell Count
Macrophages
T-Lymphocytes

Citeer dit

van Rijswijk, Jan Willem ; Farag, Emile S. ; Bouten, Carlijn V.C. ; de Boer, Onno J. ; van der Wal, Allard ; de Mol, Bas A.J.M. ; Kluin, Jolanda. / Fibrotic aortic valve disease after radiotherapy : an immunohistochemical study in breast cancer and lymphoma patients. In: Cardiovascular Pathology. 2020 ; Vol. 45.
@article{4d44debfdac84a749762a90a0fd6d187,
title = "Fibrotic aortic valve disease after radiotherapy: an immunohistochemical study in breast cancer and lymphoma patients",
abstract = "BACKGROUND: Radiation-associated aortic valve (AV) stenosis is frequently seen as a late sequela after thoracic radiotherapy (RT). Although the clinical relationship between thoracic radiotherapy and valvular dysfunction has been established, the process leading to accelerated aortic valve stenosis remains unclear. The aim of this study was to determine whether increased inflammatory cell infiltration, fibrosis, and calcification is present in aortic valves after radiotherapy at the time of aortic valve replacement.METHODS: Stenotic aortic valve specimens from 43 patients were obtained after surgical aortic valve replacement. A total 28 patients had previously undergone radiotherapy for breast cancer or malignant lymphoma. A total 15 patients were included as control. The valve leaflets were assessed by (immuno)histochemistry for inflammatory cell composition (CD3, CD20, CD68, and CD163) and extracellular matrix changes (collagen and calcification).RESULTS: Aortic valve cell density after radiotherapy for lymphoma was markedly decreased when compared with other groups. Irradiated aortic valve show similar (low) degrees of late T and B lymphocyte infiltration as control valves, whereas macrophage marker CD68 was decreased after radiotherapy for breast cancer. Collagen content was increased following radiotherapy. Aortic valves of patients with lymphoma contained significantly less calcified tissue when compared with the other groups.CONCLUSION: High-dose radiation at a young age (patients with lymphoma) results in cell loss and premature fibrotic aortic valve stenosis as opposed to the degenerative calcific stenosis observed in patients with breast cancer. Our findings suggest a possible dose-dependent effect of radiotherapy on aortic valve fibrosis. The active presence of inflammatory cells may be limited to the acute phase after radiotherapy.",
keywords = "Aortic stenosis, Aortic valve, Fibrosis, Late effects, Radiotherapy",
author = "{van Rijswijk}, {Jan Willem} and Farag, {Emile S.} and Bouten, {Carlijn V.C.} and {de Boer}, {Onno J.} and {van der Wal}, Allard and {de Mol}, {Bas A.J.M.} and Jolanda Kluin",
year = "2020",
month = "3",
day = "1",
doi = "10.1016/j.carpath.2019.107176",
language = "English",
volume = "45",
journal = "Cardiovascular Pathology",
issn = "1054-8807",
publisher = "Elsevier",

}

Fibrotic aortic valve disease after radiotherapy : an immunohistochemical study in breast cancer and lymphoma patients. / van Rijswijk, Jan Willem (Corresponding author); Farag, Emile S.; Bouten, Carlijn V.C.; de Boer, Onno J.; van der Wal, Allard; de Mol, Bas A.J.M.; Kluin, Jolanda (Corresponding author).

In: Cardiovascular Pathology, Vol. 45, 107176, 01.03.2020.

Onderzoeksoutput: Bijdrage aan tijdschriftTijdschriftartikelAcademicpeer review

TY - JOUR

T1 - Fibrotic aortic valve disease after radiotherapy

T2 - an immunohistochemical study in breast cancer and lymphoma patients

AU - van Rijswijk, Jan Willem

AU - Farag, Emile S.

AU - Bouten, Carlijn V.C.

AU - de Boer, Onno J.

AU - van der Wal, Allard

AU - de Mol, Bas A.J.M.

AU - Kluin, Jolanda

PY - 2020/3/1

Y1 - 2020/3/1

N2 - BACKGROUND: Radiation-associated aortic valve (AV) stenosis is frequently seen as a late sequela after thoracic radiotherapy (RT). Although the clinical relationship between thoracic radiotherapy and valvular dysfunction has been established, the process leading to accelerated aortic valve stenosis remains unclear. The aim of this study was to determine whether increased inflammatory cell infiltration, fibrosis, and calcification is present in aortic valves after radiotherapy at the time of aortic valve replacement.METHODS: Stenotic aortic valve specimens from 43 patients were obtained after surgical aortic valve replacement. A total 28 patients had previously undergone radiotherapy for breast cancer or malignant lymphoma. A total 15 patients were included as control. The valve leaflets were assessed by (immuno)histochemistry for inflammatory cell composition (CD3, CD20, CD68, and CD163) and extracellular matrix changes (collagen and calcification).RESULTS: Aortic valve cell density after radiotherapy for lymphoma was markedly decreased when compared with other groups. Irradiated aortic valve show similar (low) degrees of late T and B lymphocyte infiltration as control valves, whereas macrophage marker CD68 was decreased after radiotherapy for breast cancer. Collagen content was increased following radiotherapy. Aortic valves of patients with lymphoma contained significantly less calcified tissue when compared with the other groups.CONCLUSION: High-dose radiation at a young age (patients with lymphoma) results in cell loss and premature fibrotic aortic valve stenosis as opposed to the degenerative calcific stenosis observed in patients with breast cancer. Our findings suggest a possible dose-dependent effect of radiotherapy on aortic valve fibrosis. The active presence of inflammatory cells may be limited to the acute phase after radiotherapy.

AB - BACKGROUND: Radiation-associated aortic valve (AV) stenosis is frequently seen as a late sequela after thoracic radiotherapy (RT). Although the clinical relationship between thoracic radiotherapy and valvular dysfunction has been established, the process leading to accelerated aortic valve stenosis remains unclear. The aim of this study was to determine whether increased inflammatory cell infiltration, fibrosis, and calcification is present in aortic valves after radiotherapy at the time of aortic valve replacement.METHODS: Stenotic aortic valve specimens from 43 patients were obtained after surgical aortic valve replacement. A total 28 patients had previously undergone radiotherapy for breast cancer or malignant lymphoma. A total 15 patients were included as control. The valve leaflets were assessed by (immuno)histochemistry for inflammatory cell composition (CD3, CD20, CD68, and CD163) and extracellular matrix changes (collagen and calcification).RESULTS: Aortic valve cell density after radiotherapy for lymphoma was markedly decreased when compared with other groups. Irradiated aortic valve show similar (low) degrees of late T and B lymphocyte infiltration as control valves, whereas macrophage marker CD68 was decreased after radiotherapy for breast cancer. Collagen content was increased following radiotherapy. Aortic valves of patients with lymphoma contained significantly less calcified tissue when compared with the other groups.CONCLUSION: High-dose radiation at a young age (patients with lymphoma) results in cell loss and premature fibrotic aortic valve stenosis as opposed to the degenerative calcific stenosis observed in patients with breast cancer. Our findings suggest a possible dose-dependent effect of radiotherapy on aortic valve fibrosis. The active presence of inflammatory cells may be limited to the acute phase after radiotherapy.

KW - Aortic stenosis

KW - Aortic valve

KW - Fibrosis

KW - Late effects

KW - Radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=85076307065&partnerID=8YFLogxK

U2 - 10.1016/j.carpath.2019.107176

DO - 10.1016/j.carpath.2019.107176

M3 - Article

C2 - 31837504

VL - 45

JO - Cardiovascular Pathology

JF - Cardiovascular Pathology

SN - 1054-8807

M1 - 107176

ER -